351 related articles for article (PubMed ID: 18723296)
41. Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF).
He XY; Liu TF; He SQ; Huan SL; Pan ZQ
Radiother Oncol; 2007 Oct; 85(1):29-35. PubMed ID: 17889386
[TBL] [Abstract][Full Text] [Related]
42. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
[TBL] [Abstract][Full Text] [Related]
43. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Kim K; Wu HG; Kim HJ; Sung MW; Kim KH; Lee SH; Heo DS; Kim HJ; Park CI
Head Neck; 2009 Sep; 31(9):1121-8. PubMed ID: 19340863
[TBL] [Abstract][Full Text] [Related]
44. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
45. Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique: analysis of 542 consecutive patients.
Jereczek-Fossa BA; Vavassori A; Fodor C; Santoro L; Zerini D; Cattani F; Garibaldi C; Cambria R; Fodor A; Boboc GI; Vitolo V; Ivaldi GB; Musi G; de Cobelli O; Orecchia R
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):784-94. PubMed ID: 18191332
[TBL] [Abstract][Full Text] [Related]
46. Late complications of radiotherapy for nasopharyngeal carcinoma.
Sumitsawan Y; Chaiyasate S; Chitapanarux I; Anansuthiwara M; Roongrotwattanasiri K; Vaseenon V; Tooncam H
Auris Nasus Larynx; 2009 Apr; 36(2):205-9. PubMed ID: 18635325
[TBL] [Abstract][Full Text] [Related]
47. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
Chen WC; Jackson A; Budnick AS; Pfister DG; Kraus DH; Hunt MA; Stambuk H; Levegrun S; Wolden SL
Cancer; 2006 Feb; 106(4):820-9. PubMed ID: 16421885
[TBL] [Abstract][Full Text] [Related]
48. A multi-institutional survey of the effectiveness of chemotherapy combined with radiotherapy for patients with nasopharyngeal carcinoma.
Kawashima M; Fuwa N; Myojin M; Nakamura K; Toita T; Saijo S; Hayashi N; Ohnishi H; Shikama N; Kano M; Yamamoto M
Jpn J Clin Oncol; 2004 Oct; 34(10):569-83. PubMed ID: 15591454
[TBL] [Abstract][Full Text] [Related]
49. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma.
Atasoy BM; Dane F; Yumuk PF; Akgün Z; Turhal NS; Abacioğlu U; Sengöz M
J BUON; 2008; 13(1):43-50. PubMed ID: 18404785
[TBL] [Abstract][Full Text] [Related]
50. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
[TBL] [Abstract][Full Text] [Related]
51. Chemotherapy with or without radiotherapy in patients with locoregionally recurrent nasopharyngeal carcinoma.
Wong ZW; Tan EH; Yap SP; Tan T; Leong SS; Fong KW; Wee J
Head Neck; 2002 Jun; 24(6):549-54. PubMed ID: 12112552
[TBL] [Abstract][Full Text] [Related]
52. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy.
Jen YM; Shih R; Lin YS; Su WF; Ku CH; Chang CS; Shueng PW; Hwang JM; Liu DW; Chao HL; Lin HY; Chang LP; Shum WY; Lin CS
Radiother Oncol; 2005 May; 75(2):204-9. PubMed ID: 15908027
[TBL] [Abstract][Full Text] [Related]
53. Treatment outcomes of patients with AJCC stage IVC nasopharyngeal carcinoma: benefits of primary radiotherapy.
Yeh SA; Tang Y; Lui CC; Huang EY
Jpn J Clin Oncol; 2006 Mar; 36(3):132-6. PubMed ID: 16520357
[TBL] [Abstract][Full Text] [Related]
54. [Radiotherapy with concurrent chemotherapy for treatment of advanced nasopharyngeal carcinoma].
Feng ZF; Pan HL; Song HS; Liu ZM; Huang Y
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):694-6. PubMed ID: 15201093
[TBL] [Abstract][Full Text] [Related]
55. Radiotherapy and chemotherapy in the conservative treatment of anal canal carcinoma.
Raffetto N; Monaco A; Banelli E
Anticancer Res; 2008; 28(2B):1335-9. PubMed ID: 18505075
[TBL] [Abstract][Full Text] [Related]
56. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
[TBL] [Abstract][Full Text] [Related]
57. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
[TBL] [Abstract][Full Text] [Related]
58. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience.
Tham IW; Hee SW; Yeo RM; Salleh PB; Lee J; Tan TW; Fong KW; Chua ET; Wee JT
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1481-6. PubMed ID: 19386431
[TBL] [Abstract][Full Text] [Related]
59. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.
Low WK; Toh ST; Wee J; Fook-Chong SM; Wang DY
J Clin Oncol; 2006 Apr; 24(12):1904-9. PubMed ID: 16622266
[TBL] [Abstract][Full Text] [Related]
60. Hypothyroidism after radiotherapy for nasopharyngeal cancer patients.
Wu YH; Wang HM; Chen HH; Lin CY; Chen EY; Fan KH; Huang SF; Chen IH; Liao CT; Cheng AJ; Chang JT
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1133-9. PubMed ID: 19596170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]